Revolution Medicines
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Revolution Medicines's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 67% to $11,580,000. Profit margin reached -3768%. Total operating expenses were $498,765,000.
Profit Margin
| 2017 | 0 | -31.12M | |
|---|---|---|---|
| 2018 | 20.16M | -41.78M | -207.24% |
| 2019 | 50.04M | -47.66M | -95.25% |
| 2020 | 42.98M | -108.15M | -251.63% |
| 2021 | 29.39M | -179.77M | -611.67% |
| 2022 | 35.38M | -248.70M | -702.95% |
| 2023 | 11.58M | -436.36M | -3768.28% |
RVMD Income Statement (2017 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
Revenue | |||||||
Revenue | 11.58M | 35.38M | 29.39M | 42.98M | 50.04M | 20.16M | 0 |
Cost of revenue | 0 | 9.65M | 7.33M | 132.25M | 91.75M | 0 | 1.18M |
Gross profit | 11.58M | 25.72M | 22.05M | -89.26M | -41.71M | 20.16M | -1.18M |
Operating exp. | |||||||
Research and development | 423.14M | 253.07M | 186.94M | 132.25M | 91.75M | 51.08M | 26.58M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 498.76M | 293.65M | 217.39M | 153.68M | 104.16M | 60.49M | 31.12M |
Operating income | -487.18M | -258.27M | -188.00M | -110.69M | -54.12M | -40.32M | -31.12M |
Other income (expenses), net | 47.29M | 9.15M | 917K | 2.16M | 2.08M | -2.12M | 2K |
Income before tax | -439.89M | -249.12M | -187.09M | -108.53M | -52.03M | -41.78M | -31.12M |
Income tax expense | -3.52M | -420K | -7.32M | -371K | -4.37M | -1.34M | 105K |
Net income | -436.36M | -248.70M | -179.77M | -108.15M | -47.66M | -41.78M | -31.12M |
Earnings per share | |||||||
Basic EPS | -3.86 | -3.08 | -2.47 | -1.62 | -0.81 | -1.15 | -0.85 |
Diluted EPS | -3.86 | -3.08 | -2.47 | -1.62 | -0.81 | -1.15 | -0.85 |
| Data source | Data source | Data source | Data source | Data source |